Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
D000241:Adenosine / Q000627:therapeutic use*; D000818:Animals; D001555:Benzene Derivatives / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002455:Cell Division; D002478:Cells, Cultured; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D007939:Leukemia L1210 / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D008811:Mice, Inbred DBA; D051381:Rats; D012510:Sarcoma 180; D013866:Thioguanine / Q000627:therapeutic use
D001555:Benzene Derivatives; D015122:Mercaptopurine; D013866:Thioguanine; D000241:Adenosine